Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA 02120-1613, USA.
J Gen Intern Med. 2012 Jul;27(7):801-7. doi: 10.1007/s11606-012-1987-7. Epub 2012 Jan 21.
It is uncertain if computerized physician order entry (CPOE) systems are effective at reducing adverse drug event (ADE) rates in community hospitals, where mainly vendor-developed applications are used.
To evaluate the impact of vendor CPOE systems on the frequency of ADEs.
Prospective before-and-after study conducted from January 2005 to September 2010 at five Massachusetts community hospitals. Participants were adults admitted during the study period. A total of 2,000 charts were reviewed for orders, medication lists, laboratory reports, admission histories, notes, discharge summaries, and flow sheets.
The primary outcome measure was the rate of preventable ADEs. Rates of potential ADEs and overall ADEs were secondary outcomes.
The rate of preventable ADEs decreased following implementation (10.6/100 vs. 7.0/100 admissions; p = 0.007) with a similar effect observed at each site. However, the associated decrease in preventable ADEs was balanced against an increase in potential ADEs (44.4/100 vs. 57.5/100 admissions; p < 0.001). We observed a reduction of 34.0% for preventable ADEs, but an increase of 29.5% in potential ADEs following implementation. The overall rate of ADEs increased (14.6/100 vs. 18.7/100 admissions; p = 0.03), which was driven by non-preventable events (4.0/100 vs. 11.7/100 admissions; p < 0.001).
Adoption of vendor CPOE systems was associated with a decrease in the preventable ADE rate by a third, although the rates of potential ADEs and overall ADEs increased. Our findings support the use of vendor CPOE systems as a means to reduce drug-related injury and harm. The potential ADE rate could be reduced by making refinements to the vendor applications and their associated decision support.
在主要使用供应商开发的应用程序的社区医院中,计算机化医嘱录入(CPOE)系统是否能有效降低不良药物事件(ADE)的发生率还不确定。
评估供应商 CPOE 系统对 ADE 发生率的影响。
2005 年 1 月至 2010 年 9 月在马萨诸塞州的五家社区医院进行的前瞻性前后对照研究。参与者为研究期间住院的成年人。共回顾了 2000 份病历,包括医嘱、用药清单、实验室报告、入院史、记录、出院小结和流程图。
主要结局指标为可预防 ADE 发生率。潜在 ADE 和总体 ADE 的发生率为次要结局。
实施后可预防 ADE 的发生率下降(10.6/100 与 7.0/100 入院;p=0.007),每个地点都观察到类似的效果。然而,可预防 ADE 的减少与潜在 ADE 的增加相平衡(44.4/100 与 57.5/100 入院;p<0.001)。我们观察到可预防 ADE 减少 34.0%,但实施后潜在 ADE 增加 29.5%。ADE 的总体发生率增加(14.6/100 与 18.7/100 入院;p=0.03),这是由不可预防的事件驱动的(4.0/100 与 11.7/100 入院;p<0.001)。
采用供应商 CPOE 系统与可预防 ADE 发生率降低三分之一相关,尽管潜在 ADE 和总体 ADE 的发生率增加。我们的研究结果支持将供应商 CPOE 系统作为减少与药物相关的伤害和危害的一种手段。通过改进供应商应用程序及其相关决策支持,可以降低潜在 ADE 的发生率。